Marton König

11PUBLICATIONS
20CO-AUTHORS
Nanotoxicology, health and safetyPeripheral nervous systemCardiology (incl. cardiovascular diseases)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 25, 2026
Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab.

Einar August Høgestøl, Åge Winje Brustad, Elisabeth Gulowsen Celius

|Mar 16, 2026
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.

Tilde Harridsleff Rasmussen, Stine Schikora-Rustad, Åslaug Rudjord Lorentzen

|Dec 31, 2025
Anti-CD20 therapies under the stethoscope: A signal from the heart.

Marton König

|Oct 21, 2021
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations.

Marton König, Åslaug Rudjord Lorentzen, Hilde Marie Torgauten

Pageof 2